GOEV vs. AMLX
GOEV (Canoo Inc.) and AMLX (Amylyx Pharmaceuticals, Inc.) are both stocks. GOEV operates in Auto Manufacturers (Consumer Cyclical), while AMLX operates in Biotechnology (Healthcare).
Performance
GOEV vs. AMLX - Performance Comparison
Loading charts...
Returns By Period
GOEV
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
AMLX
- 1D
- -0.68%
- 1M
- -19.81%
- YTD
- 9.27%
- 6M
- -7.11%
- 1Y
- 157.81%
- 3Y*
- -19.37%
- 5Y*
- —
- 10Y*
- —
GOEV vs. AMLX - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
GOEV Canoo Inc. | 0.00% |
AMLX Amylyx Pharmaceuticals, Inc. | -5.58% |
Fundamentals
GOEV:
$1.86M
AMLX:
$0.00
GOEV:
-$11.59M
AMLX:
-$20.10M
GOEV:
-$118.67M
AMLX:
-$150.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GOEV vs. AMLX — Risk / Return Rank
GOEV
AMLX
GOEV vs. AMLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Canoo Inc. (GOEV) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| GOEV | AMLX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 2.37 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | -0.08 | — |
Drawdowns
GOEV vs. AMLX - Drawdown Comparison
The maximum GOEV drawdown since its inception was 0.00%, smaller than the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for GOEV and AMLX.
Loading charts...
Drawdown Indicators
| GOEV | AMLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -96.04% | +96.04% |
Max Drawdown (1Y)Largest decline over 1 year | — | -30.61% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -93.83% | — |
Current DrawdownCurrent decline from peak | 0.00% | -67.75% | +67.75% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -59.36% | +59.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 13.52% | — |
Volatility
GOEV vs. AMLX - Volatility Comparison
Loading charts...
Volatility by Period
| GOEV | AMLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 14.15% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 41.86% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 66.96% | -66.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 91.49% | -91.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 91.49% | -91.49% |
Dividends
GOEV vs. AMLX - Dividend Comparison
Neither GOEV nor AMLX has paid dividends to shareholders.
Financials
GOEV vs. AMLX - Financials Comparison
This section allows you to compare key financial metrics between Canoo Inc. and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Find the right allocation for GOEV and AMLX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer